Clozapine Orally-Disentegrating Tablets Clinical Trials

• Equivalence of Generic Clozapine to Orally Dissolving Clozapine in Schizophrenia or Schizoaffective Disorder
  ClinicalTrials.gov Identifier: NCT00501618 - Recruiting
  Schizophrenia; Schizoaffective Disorder
  
• A MULTICENTER, OPEN-LABEL, RANDOMIZED CROSSOVER TRIAL TO ASSESS SUBJECT PREFERENCE FOR ALPRAZOLAM ORALLY DISINTEGRATING TABLETS COMPARED TO CONVENTIONAL ALPRAZOLAM TABLETS IN SUBJECTS WITH ANXIETY
  ClinicalTrials.gov Identifier: NCT00139854 - Completed
  Anxiety
  
• A Long Term Study of Clozapine in Patients with Treatment-Resistant Schizophrenia
  ClinicalTrials.gov Identifier: NCT00154258 - Active, not recruiting
  Schizophrenia
  
• Study of AKR-501 Tablets Taken Orally Once Daily for 28 Days in Patients With ITP
  ClinicalTrials.gov Identifier: NCT00441090 - Recruiting
  Chronic Idiopathic Thrombocytopenic Purpura (ITP)
  
• Randomized Evaluation of the Effectiveness of Clozapine and Aripiprazole Versus Clozapine and Haloperidol in the Treatment of Schizophrenia
  ClinicalTrials.gov Identifier: NCT00395915 - Recruiting
  Schizophrenia
  
• Study of Clozapine for the Treatment of Psychosis in Patients with Idiopathic Parkinson's Disease
  ClinicalTrials.gov Identifier: NCT00004826 - Active, not recruiting
  Parkinson Disease
  
• Clozapine IM and Aggression in Schizophrenic Patients
  ClinicalTrials.gov Identifier: NCT00189995 - Not yet recruiting
  Schizophrenia
  
• Comparison of Clozapine or Olanzapine in Childhood-Onset Psychotic Disorders
  ClinicalTrials.gov Identifier: NCT00001656 - Active, not recruiting
  Mental Disorder Diagnosed in Childhood; Psychotic Disorder; Schizophrenia
  
• A Multicenter, Open-Label Trial to Assess Subject Preference of PARCOPA, Carbidopa/Levodopa Orally Disintegrating Tablets, Compared to Conventional Carbidopa/Levodopa Tablets in Subjects with Stable Parkinson''s Disease
  ClinicalTrials.gov Identifier: NCT00139867 - Completed
  Parkinson''s Disease
  
• Benzamide Derivates as Treatment of Clozapine-Induced Hypersalivation
  ClinicalTrials.gov Identifier: NCT00534573 - Not yet recruiting
  Clozapine-Induced Hypersalivation
  
• Rosiglitazone for Clozapine Induced Glucose Metabolism Impairment
  ClinicalTrials.gov Identifier: NCT00337350 - Active, not recruiting
  Schizophrenia
  
• Study of the Effectiveness and Tolerability of OROS Hydromorphone HCI SR(Slow-Release) Tablets and Immediate-Release Hydromorphone Tablets in Patients With Chronic Pain
  ClinicalTrials.gov Identifier: NCT00410943 - Active, not recruiting
  Pain
  
• Clozapine-Augmentation With Ziprasidone or Risperidone, a Randomized, Prospective Trial
  ClinicalTrials.gov Identifier: NCT00224315 - Active, not recruiting
  Schizophrenia, Schizoaffective Disorder
  
• PK, PD and Safety of Multiple Doses of V1512 Tablets in PD Patients Compared to Standard Levodopa/Carbidopa Oral Tablets
  ClinicalTrials.gov Identifier: NCT00491998 - Recruiting
  Parkinson's Disease
  
• Aripiprazole Augmentation for Clozapine-Treated Patients With Refractory Schizophrenia
  ClinicalTrials.gov Identifier: NCT00328367 - Active, not recruiting
  Schizophrenia
  
• A Study to Evaluate the Safety and Efficacy of Clozapine in Patients With Treatment-Resistant Schizophrenia
  ClinicalTrials.gov Identifier: NCT00250575 - Active, not recruiting
  Schizophrenia
  
• Efficacy of Pimozide Augmentation for Clozapine Partial Response
  ClinicalTrials.gov Identifier: NCT00374244 - Recruiting
  Schizophrenia
  
• Atomoxetine for Treatment of Weight Gain in Olanzapine or Clozapine Patients
  ClinicalTrials.gov Identifier: NCT00176436 - Recruiting
  Schizophrenia
  
• Relationship Between Neurotransmitter Receptor Polymorphisms, Plasma Concentrations and Clinical Response to Clozapine
  ClinicalTrials.gov Identifier: NCT00581932 - Recruiting
  Schizophrenia
  
• Electroconvulsive Therapy in Clozapine Refractory Schizophrenia
  ClinicalTrials.gov Identifier: NCT00042224 - Active, not recruiting
  Schizophrenia
  
• Clozapine for Treatment-Resistant Mania
  ClinicalTrials.gov Identifier: NCT00029458 - Completed
  Bipolar Disorder
  
• Treatment of Schizophrenia and Comorbid Cannabis Use Disorder: Comparing Clozapine to Risperidone and Olanzapine.
  ClinicalTrials.gov Identifier: NCT00149955 - Recruiting
  Schizophrenia; Dual Diagnosis; Schizoaffective Disorder; Psychotic Disorder; Substance Abuse; Cannabis Abuse
  
• Treatment of Clozapine-Induced Hypersalivation Ipratropium Bromide
  ClinicalTrials.gov Identifier: NCT00381589 - Recruiting
  Hypersalivation
  
• Safety and Pharmacokinetics of XL647 Administered Orally to Subjects with Solid Tumors
  ClinicalTrials.gov Identifier: NCT00086528 - Active, not recruiting
  Cancer
  
• Effectiveness of Aripiprazole for Improving Side Effects of Clozapine in the Treatment of People With Schizophrenia
  ClinicalTrials.gov Identifier: NCT00345033 - Recruiting
  Schizophrenia; Insulin Resistance
  
• Study of XL820 Given Orally Daily to Subjects With Solid Tumors
  ClinicalTrials.gov Identifier: NCT00350831 - Recruiting
  Cancer
  
• Genetics of Response to Clozapine and Other Antipsychotic Drugs and Vulnerability to Hallucinations
  ClinicalTrials.gov Identifier: NCT00178932 - Recruiting
  Schizophrenia; Schizoaffective Disorder; Bipolar Disorder; Major Depression
  
• Augmenting Clozapine With Sertindole - SERCLOZ
  ClinicalTrials.gov Identifier: NCT00345982 - Not yet recruiting
  Schizophrenia
  
• Study of XL647 Administered Orally Daily to Patients With Solid Tumors
  ClinicalTrials.gov Identifier: NCT00336765 - Recruiting
  Cancer
  
• Outpatient Cervical Ripening With Orally Administered Misoprostol in Diabetics
  ClinicalTrials.gov Identifier: NCT00514618 - Recruiting
  Diabetes, Gestational
  
• A Randomized, Open-Label, Two-Way Crossover Trial to Determine the Pharmacokinetics of Metoclopramide When Administered as the Orally Disintegrating Tablet Compared to Reglan® Tablets in Subjects with Diabetic Gastroparesis
  ClinicalTrials.gov Identifier: NCT00139893 - Completed
  Diabetic gastroparesis
  
• Study Evaluating Orally Administered Moxidectin in Subjects With Onchocerca Volvulus Infection
  ClinicalTrials.gov Identifier: NCT00300768 - Recruiting
  Onchocerciasis
  
• Comparison Between Systemic Exposure to Ciclesonide Nasal Spray, Ciclesonide HFA Nasal Aerosol and Orally Inhaled Ciclesonide (BY9010/M1-422)
  ClinicalTrials.gov Identifier: NCT00458835 - Active, not recruiting
  Allergic Rhinitis
  
• Treating Drug-Resistant Childhood Schizophrenia
  ClinicalTrials.gov Identifier: NCT00048828 - Recruiting
  Schizophrenia
  
• Oxycodone-Naloxone Prolonged Release Tablets in Relieving Opioid-Related Constipation
  ClinicalTrials.gov Identifier: NCT00412100 - Active, not recruiting
  Pain
  
• An Open-Label Evaluation of the Dose Proportionality of OROS® Hydromorphone HCL Tablets 8mg, 16mg, 32mg, 64mg
  ClinicalTrials.gov Identifier: NCT00398957 - Active, not recruiting
  Analgesia
  
• Phase III Study to Assess the Long Term Efficacy, Carry-Over Effect and Safety of 300 IR Sublingual Immunotherapy Tablets
  ClinicalTrials.gov Identifier: NCT00418379 - Active, not recruiting
  Allergy
  
• A Comparison of Orally Pilocarpine and Artificial Saliva in Xerostomy Treatment.
  ClinicalTrials.gov Identifier: NCT00438048 - Recruiting
  Primary Sjogren; Secondary Sjogren; Xerostomia
  
• Sirolimus Blood Concentrations on Conversion From Oral Solution to Tablets
  ClinicalTrials.gov Identifier: NCT00166842 - Active, not recruiting
  Transplantation; Kidney Transplantation; Immunosuppression
  
• Long-Term Administration Study of SND 919 Tablets in Parkinson's Disease
  ClinicalTrials.gov Identifier: NCT00274131 - Active, not recruiting
  Parkinson Disease
  
• A Study Of The Safety And Tolerability Of HKI-272 Administered Orally To Japanese Subjects With Advanced Solid Tumors
  ClinicalTrials.gov Identifier: NCT00397046 - Recruiting
  Tumors
  
• Efficacy of Orally Disintegrating Selegiline in Parkinson's Patients Experiencing Adverse Effects With Dopamine Agonists
  ClinicalTrials.gov Identifier: NCT00443872 - Recruiting
  Parkinson's Disease
  
• Changes in the Immune Response and Skin Reactivity of Grass Pollen Allergic Patients Treated With ALK Grass Tablets
  ClinicalTrials.gov Identifier: NCT00413556 - Active, not recruiting
  Allergy
  
• Risperidone Treatment in Schizophrenia Patients Who Are Currently Taking Clozapine
  ClinicalTrials.gov Identifier: NCT00056498 - Recruiting
  Schizophrenia
  
• Safety, Tolerability, Pharmacodynamic and Pharmacokinetic Effects of Single and Multiple-Doses of ATF936 and AXT914 Administered Orally in Healthy Subjects.
  ClinicalTrials.gov Identifier: NCT00417261 - Recruiting
  Healthy
  
• Efficacy and Safety Study of Clozapine Augmented by Atomoxetine Versus Clozapine Augmented by Placebo in Patients with Chronic Resistant Schizophrenia
  ClinicalTrials.gov Identifier: NCT00216281 - Terminated
  Schizophrenia
  
• A Randomized, Double-Blind, Placebo-Controlled Trial with 0.75mg Pramipexole (BI•Sifrol®) Orally Once Daily to Investigate the Efficacy and Safety for 6 Weeks in Patients with Primary Restless Legs Syndrome.
  ClinicalTrials.gov Identifier: NCT00152997 - Completed
  Restless Legs Syndrome
  
• A Study of Relapse Prevention and the Effectiveness of Long-Acting Injectable Risperidone and Quetiapine Tablets in the Treatment of Patients With Schizophrenia or Schiozaffective Disorder
  ClinicalTrials.gov Identifier: NCT00216476 - Active, not recruiting
  Schizophrenia; Psychotic Disorders
  
• A Repeated Dose Study of the Metabolism and Action Evaluation of OROS Hydromorphone HCI (Slow Release) Tablets in Patients With Chronic Pain
  ClinicalTrials.gov Identifier: NCT00410878 - Active, not recruiting
  Analgesics, Opioid.; Pain
  
• PK/PD and Steady State Efficacy Study of Bilastine Compared With Placebo Given Orally in the Treatment of the Symptoms of SAR in an EEC Model (5-Arm)
  ClinicalTrials.gov Identifier: NCT00574210 - Recruiting
  Seasonal Allergic Rhinitis; Hay Fever; Rhinoconjunctivitis
  
• Adefovir Dipivoxil Tablets (10mg) In Chinese Subjects With HBe Antigen Negative Chronic Hepatitis B
  ClinicalTrials.gov Identifier: NCT00324961 - Active, not recruiting
  Chronic Hepatitis B
  
• A Study of the Efficacy and Safety of Long-Acting Injectable Risperidone and Risperidone Tablets in Patients With Schizophrenia
  ClinicalTrials.gov Identifier: NCT00240708 - Active, not recruiting
  Schizophrenia
  
• Conversion To Monotherapy With Lamictal Extended Release Tablets For Treatment Of Partial Epilepsy
  ClinicalTrials.gov Identifier: NCT00355082 - Active, not recruiting
  Epilepsy, Partial
  
• A Dose Escalation of Gimatecan Administered Orally to Japanese Patients With Advanced Solid Tumor.
  ClinicalTrials.gov Identifier: NCT00410358 - Recruiting
  Advanced Solid Tumors
  
• Safety and Efficacy of Orally Administered Laquinimod for Treatment of Relapsing Remitting Multiple Sclerosis (RRMS)
  ClinicalTrials.gov Identifier: NCT00509145 - Recruiting
  Multiple Sclerosis
  
• An Extension Trial to a Phase I Dose Escalation Study of Gimatecan Administered Orally 5 Consecutive Days to Japanese Patients With Advanced Solid Tumor
  ClinicalTrials.gov Identifier: NCT00441610 - Recruiting
  Advanced Solid Tumors
  
• Lopinavir Capsules to Kaletra or Invirase Tablets
  ClinicalTrials.gov Identifier: NCT00438152 - Recruiting
  HIV Infections
  
• Treatment of Schizophrenia and Comorbid Cannabis Use Disorder: Comparing Clozapine to Treatment-as-Usual
  ClinicalTrials.gov Identifier: NCT00498550 - Recruiting
  Schizophrenia; Dual Diagnosis; Schizoaffective Disorder; Psychotic Disorder; Cannabis Abuse
  
• A Study of the Safety, and Anti-Tumor Activity of ADH300004 and 5-Fluorouracil Administered Orally in a Weekly Schedule to Subjects With Locally Advanced, Recurrent, or Metastatic Hepatocellular Carcinoma
  ClinicalTrials.gov Identifier: NCT00319683 - Recruiting
  Hepatocellular Carcinoma
  
• Effectiveness of Pimozide in Augmenting the Effects of Clozapine in the Treatment of Schizophrenia
  ClinicalTrials.gov Identifier: NCT00158223 - Recruiting
  Schizophrenia; Psychotic Disorders
  
• Clinical Trial to Evaluate the Efficacy and the Safety of Antihypertensive Tablets
  ClinicalTrials.gov Identifier: NCT00553865 - Recruiting
  Essential Hypertension
  
• A Phase I Dose Escalation Study of LBQ707 (Gimatecan) Administered Orally Twice Per Week to Japanese Patients With Advanced Solid Tumors
  ClinicalTrials.gov Identifier: NCT00487058 - Recruiting
  Advanced Solid Tumors
  
• A Study of the Safety, Pharmacokinetics of 5 Fluorouracil, and Anti-Tumor Activity of ADH300004 and 5 Fluorouracil Administered Orally to Subjects With Incurable Solid Tumors.
  ClinicalTrials.gov Identifier: NCT00264472 - Recruiting
  Neoplasms
  
• Study to Evaluate the Efficacy and Safety of Orally Administered Rob 803 When Added to Methotrexate
  ClinicalTrials.gov Identifier: NCT00525213 - Not yet recruiting
  Rheumatoid Arthritis
  
• Safety, Tolerability and Pharmacodynamic Effects of Sublingual Immunotherapy (Tablets) With Recombinant Bet v1
  ClinicalTrials.gov Identifier: NCT00396149 - Recruiting
  Allergy
  
• A Long-Term Safety Study to Evaluate Methylphenidate HCL Tablets at Multiple Dose Levels in Adults With Attention Deficit Hyperactivity Disorder
  ClinicalTrials.gov Identifier: NCT00326300 - Active, not recruiting
  Attention Deficit Hyperactivity Disorder
  
• Efficacy and Safety of 300 IR Sublingual Immunotherapy (SLIT) Tablets in Children Suffering From Grass Pollen Rhinoconjunctivitis
  ClinicalTrials.gov Identifier: NCT00409409 - Recruiting
  Allergy
  
• Itraconazole Tablets Vs. Itraconazole Capsules vs. Placebo in Onychomycosis of the Toenail.
  ClinicalTrials.gov Identifier: NCT00356915 - Active, not recruiting
  Onychomycosis of the Toenail
  
• A Study to Evaluate Orally-Administered Oseltamivir and Intravenous Zanamivir in Healthy Subjects
  ClinicalTrials.gov Identifier: NCT00540501 - Not yet recruiting
  Healthy Volunteer
  
• Study Evaluating the Safety, Tolerability, and Pharmacokinetics (PK) of HKI-357 Administered Orally to Healthy Subjects
  ClinicalTrials.gov Identifier: NCT00550381 - Not yet recruiting
  Healthy
  
• Efficacy and Safety of Fentanyl Buccal Tablets Compared With Oxycodone for the Management of Break Through Pain
  ClinicalTrials.gov Identifier: NCT00463047 - Recruiting
  Chronic Pain
  
• Pyronaridine Artesunate 3:1 Granule Formulation vs. Coartem© Crushed Tablets in P. Falciparum Malaria Pediatric Patients
  ClinicalTrials.gov Identifier: NCT00541385 - Recruiting
  Malaria
  
• Rosiglitazone (Extended Release Tablets) As Adjunctive Therapy For Subjects With Mild To Moderate Alzheimer's Disease
  ClinicalTrials.gov Identifier: NCT00348309 - Recruiting
  Alzheimer Disease
  
• An Observational Study of Olanzapine Coated and Orodispersible Tablets Effectiveness in Schizophrenic and Bipolar Outpatients.
  ClinicalTrials.gov Identifier: NCT00510211 - Recruiting
  Schizophrenia; Bipolar Disorder
  
• Factors Predicting Efficacy of Allergen Injection Immunotherapy for Grass Pollen Hayfever: a Pilot Study.
  ClinicalTrials.gov Identifier: NCT00135629 - Active, not recruiting
  Seasonal Allergic Rhinoconjunctivitis
  
• Study of Talabostat and Rituximab in Advanced Chronic Lymphocytic Leukemia (CLL)
  ClinicalTrials.gov Identifier: NCT00086203 - Active, not recruiting
  Chronic Lymphocytic Leukemia
  
• The Efficacy of ESTRATEST® Tablets in Relieving Menopausal Symptoms in Estrogenized, Hysterectomized Postmenopausal Women
  ClinicalTrials.gov Identifier: NCT00141557 - Recruiting
  Menopause
  
• A Phase 3, Randomized, Open-Label, Study of Lopinavir/Ritonavir Tablets Versus Soft Gel Capsules and Once Daily Versus Twice-Daily Administration, When Co-Administered With NRTIs in Antiretroviral Naive HIV-1 Infected Subjects
  ClinicalTrials.gov Identifier: NCT00262522 - Active, not recruiting
  HIV Infection
  
• Rosiglitazone (Extended Release Tablets) As Adjunctive Therapy In Subjects With Mild To Moderate Alzheimer's Disease
  ClinicalTrials.gov Identifier: NCT00348140 - Recruiting
  Alzheimer's Disease
  
• Rosiglitazone (Extended Release Tablets) Monotherapy In Subjects With Mild To Moderate Alzheimer's Disease
  ClinicalTrials.gov Identifier: NCT00428090 - Recruiting
  Alzheimer's Disease
  
• A Study of Lopinavir/Ritonavir Tablets Comparing Once-Daily Versus Twice-Daily Dosing in Antiretroviral-Experienced, HIV-1 Infected Subjects
  ClinicalTrials.gov Identifier: NCT00358917 - Recruiting
  HIV Infection
  
• Clozapine and Risperidone for Treatment of First Episode Schizophrenia and Cannabis Use Disorder
  ClinicalTrials.gov Identifier: NCT00063349 - Suspended
  Schizophrenia; Marijuana Abuse
  
• The Efficacy of ESTRATEST® Tablets in Relieving Menopausal Symptoms in Estrogenized, Non-Hysterectomized Postmenopausal Women
  ClinicalTrials.gov Identifier: NCT00141544 - Recruiting
  Menopause
  
• Long-Term Safety Study of Sublingual Fentanyl Tablets in Cancer Patients
  ClinicalTrials.gov Identifier: NCT00263575 - Recruiting
  Pain; Cancer
  
• Mycophenolate Mofetil in Membranous Nephropathy
  ClinicalTrials.gov Identifier: NCT00135967 - Completed
  Glomerulonephritis, Membranous
  
• Ziprasidone for Clozapine- or Olanzapine-Associated Diabetes Mellitus
  ClinicalTrials.gov Identifier: NCT00351000 - Completed
  Schizophrenia
  
• Efficacy and Safety of Sublingual Fentanyl Tablets in Treatment of Breakthrough Pain in Cancer Patients.
  ClinicalTrials.gov Identifier: NCT00262678 - Recruiting
  Pain; Cancer
  
• Fuzheng Huayu Tablets Against Posthepatitic Cirrhosis
  ClinicalTrials.gov Identifier: NCT00543426 - Recruiting
  Posthepatitic Cirrhosis
  
• Post Marketing Surveillance Study to Observe Safety and Efficacy of Champix® Tablets
  ClinicalTrials.gov Identifier: NCT00483002 - Not yet recruiting
  Smoking Cessation
  
• Study of Nitazoxanide Tablets in the Treatment of Mild to Moderate Active Crohn''s Disease
  ClinicalTrials.gov Identifier: NCT00130390 - Recruiting
  Crohn''s Disease
  
• Effect of Adjuvant Treatment With Compound Cranberry Extract Tablets in Acute Bacterial Cystitis.
  ClinicalTrials.gov Identifier: NCT00305071 - Not yet recruiting
  Pyuria; Urinary Tract Infections
  
• Study of TLK199 Tablets in Myelodysplastic Syndrome (MDS)
  ClinicalTrials.gov Identifier: NCT00280631 - Recruiting
  Myelodysplastic Syndrome (MDS)
  
• Effects of Cranberry-Containing Products in Women with Recurrent Urinary Tract Infections (UTIs)
  ClinicalTrials.gov Identifier: NCT00100061 - Recruiting
  Urinary Tract Infection
  
• A Study To Look At The Starting Dose Of Ropinirole Immediate Release Tablets In Young Patients With Restless Legs Syndrome
  ClinicalTrials.gov Identifier: NCT00140712 - Recruiting
  Restless Legs Syndrome
  
• Olanzapine Versus Clozapine in Treatment Refractory Schizophrenia
  ClinicalTrials.gov Identifier: NCT00179231 - Completed
  Schizophrenia; Schizoaffective Disorder
  
• A Placebo-Controlled Trial of Modafinil (Provigil) Added to Clozapine in Patients With Schizophrenia
  ClinicalTrials.gov Identifier: NCT00573417 - Completed
  Schizophrenia
  
• Clinical Evaluation of Ropinirole PR/XR Tablets in Monotherapy for Parkinson's Disease (PD)
  ClinicalTrials.gov Identifier: NCT00434304 - Not yet recruiting
  Parkinson's Disease
  
• A Placebo-Controlled Trial Ampakine Added to Clozapine, Olanzapine or Risperidone in Patients With Schizophrenia
  ClinicalTrials.gov Identifier: NCT00235352 - Completed
  Schizophrenia
  
• Smoking Cessation With Smokeless Tobacco, Nicotine Tablets and Nicotine Patches
  ClinicalTrials.gov Identifier: NCT00313105 - Not yet recruiting
  Tobacco Dependence
  
• Oral CF101 Tablets and Methotrexate Treatment in Rheumatoid Arthritis Patients
  ClinicalTrials.gov Identifier: NCT00556894 - Not yet recruiting
  Rheumatoid Arthritis